NM_001101362.3:c.1184C>T
Variant summary
Our verdict is Likely benign. The variant received -2 ACMG points: 3P and 5B. PM1PP3BP6BS2
The NM_001101362.3(KBTBD13):c.1184C>T(p.Thr395Met) variant causes a missense change. The variant allele was found at a frequency of 0.0000995 in 1,608,652 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. T395R) has been classified as Uncertain significance.
Frequency
Consequence
NM_001101362.3 missense
Scores
Clinical Significance
Conservation
Publications
- nemaline myopathy 6Inheritance: AD, Unknown Classification: DEFINITIVE, STRONG, MODERATE, LIMITED Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae), ClinGen, G2P
 - childhood-onset nemaline myopathyInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
 
Genome browser will be placed here
ACMG classification
Our verdict: Likely_benign. The variant received -2 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes   AF:  0.0000329  AC: 5AN: 152206Hom.:  0  Cov.: 34 show subpopulations 
GnomAD2 exomes  AF:  0.0000337  AC: 8AN: 237734 AF XY:  0.0000305   show subpopulations 
GnomAD4 exome  AF:  0.000106  AC: 155AN: 1456446Hom.:  0  Cov.: 83 AF XY:  0.0000938  AC XY: 68AN XY: 724846 show subpopulations 
Age Distribution
GnomAD4 genome   AF:  0.0000329  AC: 5AN: 152206Hom.:  0  Cov.: 34 AF XY:  0.0000538  AC XY: 4AN XY: 74346 show subpopulations 
Age Distribution
ClinVar
Submissions by phenotype
Nemaline myopathy 6    Uncertain:1Benign:1 
- -
- -
Inborn genetic diseases    Uncertain:1 
The c.1184C>T (p.T395M) alteration is located in exon 1 (coding exon 1) of the KBTBD13 gene. This alteration results from a C to T substitution at nucleotide position 1184, causing the threonine (T) at amino acid position 395 to be replaced by a methionine (M). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source: 
Splicing
 Find out detailed SpliceAI scores and Pangolin per-transcript scores at